Longboard Pharmaceuticals’ stock soars amid Lundbeck’s $2.6 billion deal to acquire the company
H. Lundbeck plans to acquire Longboard Pharmaceuticals in a $2.6 billion deal, the companies announced Monday.
Lundbeck to Buy Longboard Pharma in $2.6 Billion Deal
H. Lundbeck A/S agreed to acquire Longboard Pharmaceuticals Inc. in a $2.6 billion deal that boosts its drug pipeline for ...
Longboard Pharma's Lucrative Exit To Lundbeck Another Coup For Management
Longboard Pharmaceuticals is being acquired by Lundbeck for $60 per share, valuing the deal at $2.6 billion. Read more on ...
GlobalData on MSN3d
Lundbeck to acquire Longboard Pharmaceuticals for $2.6bn
Lundbeck is to acquire Longboard for $2.6bn equity value in a move set to enhance its capabilities within neuro-rare ...
MM&M2d
Lundbeck picks up Longboard Pharmaceuticals for $2.6B
Lundbeck’s acquisition of Longboard Pharmaceuticals is meant to bolster its neuro-rare disease franchise, the drugmaker ...
STAT4d
Lundbeck to buy neurology-focused Longboard Pharmaceuticals in $2.6 billion deal
The Danish pharma company Lundbeck said Monday it would buy Longboard Pharmaceuticals in a deal worth $2.6 billion ...
pharmaphorum3d
Lundbeck drops in on epilepsy drug with $2.6bn Longboard bid
Neuroscience specialist Lundbeck has agreed to buy Longboard Pharmaceuticals for $2.6 billion, expanding its pipeline with an ...
Crain's Chicago Business3d
Lundbeck to buy California pharma in $2.6 billion deal
The Danish pharmaceutical company, with its US headquarters in Deerfield, is boosting its drug pipeline for serious brain ...
Danish pharma giant buys San Diego company’s epilepsy drug for $2.6B
Lundbeck, a global drugmaker based in Denmark, has agreed to buy La Jolla-based Longboard Pharmaceuticals for $2.6 billion to ...
Denmark's Lundbeck to buy Longboard Pharma in $2.6 billion deal
The companies said Lundbeck will acquire all of Longboard's shares for $60 per share, which represents a premium of 54.2% to ...
Business Wire4d
Lundbeck to Acquire Longboard Pharmaceuticals in a Strategic Deal, Significantly Enhancing Its Neuroscience Pipeline
VALBY, Denmark & LA JOLLA, Calif.--(BUSINESS WIRE)--H. Lundbeck A/S (Lundbeck) and Longboard Pharmaceuticals, Inc (NASDAQ: LBPH) (Longboard) today announced an agreement for Lundbeck to acquire ...
H. Lundbeck to Buy Longboard Pharmaceuticals for $2.6 Billion -- Update
Danish drugmaker H. Lundbeck has struck a deal to buy clinical-stage biopharmaceutical company Longboard Pharmaceuticals for about $2.6 billion. The companies on Monday said Lundbeck will pay $60 a ...